Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Hialeah, Florida Clinical Trials

A listing of Hialeah, Florida clinical trials actively recruiting patient volunteers.

RESULTS

Found (237) clinical trials

Efficacy and Safety of TD-1473 in Crohn's Disease

A Phase 2 multi-center, randomized, double blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of 12 weeks of induction therapy with TD1473 in subjects with moderately-to-severely active CD. This study includes 3 phases: Screening, Induction, and Active Treatment Extension (ATE). The Induction phase of the study is a …

Phase

0.37 miles

Learn More »

This phase 2 study is a multicenter, exploratory study designed to evaluate the efficiency and safety of Febuxostat 40 mg in subjects with Gout and moderate renal impairment.

Phase

0.37 miles

Learn More »

Oral Ifetroban to Treat Aspirin Exacerbated Respiratory Disease (AERD)

This is a randomized, placebo-controlled, double-blind phase 2 trial evaluating approximately 76 subjects with symptomatic AERD on the safety and efficacy of 8 weeks of oral ifetroban treatment. Eligible AERD subjects will be randomized to receive 8 weeks of either oral ifetroban daily or matching placebo followed by a 2-week …

Phase

0.37 miles

Learn More »

A Study to Assess Immunization Responses in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Treated With Nemolizumab

This is a randomized, double-blind, placebo-controlled, multi-center, parallel-group study in adult and adolescent subjects ( 12 to 54 years) with moderate-to-severe AD. Eligible subjects must have a documented history of inadequate response to topical AD medication(s). Approximately 200 subjects will be randomized 1:1 to receive either 30 mg nemolizumab (with …

Phase

0.52 miles

Learn More »

Phase 2 Dose-finding IMU-838 for Ulcerative Colitis

The investigational medicinal product (IMP) IMU-838 (vidofludimus calcium) is a new compound that selectively inhibits the human enzyme dihydroorotate dehydrogenase (DHODH). Dihydroorotate dehydrogenase plays a major role in the de-novo pyrimidine synthesis and is specifically expressed at high levels in proliferating or activated lymphocytes. Resting lymphocytes satisfy their pyrimidine requirements …

Phase

0.52 miles

Learn More »

LIFT Study: A Safety Tolerability Efficacy and Pharmacokinetics Study of TERN-101 in Subjects With Non-Cirrhotic Non-Alcoholic Steatohepatitis (NASH)

This is a Phase 2, randomized, double-blind, placebo-controlled study designed to evaluate the safety, tolerability, efficacy, and pharmacokinetics (PK) of TERN-101 in non-cirrhotic NASH patients.

Phase

0.52 miles

Learn More »

An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis [EXPEDITION]

The present study (3151-201-008) seeks to evaluate the efficacy and safety of brazikumab versus placebo in patients with moderately to severely active UC and will include assessments of clinical responses as demonstrated by improvement of symptoms and of colonic mucosal appearance as observed on endoscopy.

Phase

1.71 miles

Learn More »

Safety Tolerability and Efficacy of the Human Cytomegalovirus Vaccine (V160) in Healthy Women 16 to 35 Years of Age (V160-002)

This study will evaluate the safety, tolerability, and efficacy of Human Cytomegalovirus (CMV) vaccine V160 administered in a 2-dose or 3-dose regimen in healthy seronegative women 16 to 35 years of age. Participants will receive blinded V160 on Day 1, Month 2, and Month 6 (3-dose regimen), V160 on Day …

Phase

1.71 miles

Learn More »

A Study to Test Whether Different Doses of BI 456906 Are Effective in Treating Adults With Type 2 Diabetes.

The main objective of the trial is to demonstrate a dose-relationship of BI 456906 on Glycosylated hemoglobin A1c (HbA1c)(absolute change) from baseline to 16 weeks relative to placebo in patients with Type 2 diabetes mellitus (T2DM). Secondary objectives are to assess the effect of BI 456906 on change in body …

Phase

1.71 miles

Learn More »

A Study of LY3819253 (LY-CoV555) in Participants With Mild to Moderate COVID-19 Illness

The purpose of this study is to measure how well LY3819253 works against the virus that causes COVID-19. LY3819253 will be given to participants with early symptoms of COVID-19, via an injection into a vein. Samples will be taken from the back of the nose to determine how much virus …

Phase

1.71 miles

Learn More »